![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: STOX2 |
Gene summary for STOX2 |
![]() |
Gene information | Species | Human | Gene symbol | STOX2 | Gene ID | 56977 |
Gene name | storkhead box 2 | |
Gene Alias | STOX2 | |
Cytomap | 4q35.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q9P2F5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
56977 | STOX2 | CCI_1 | Human | Cervix | CC | 1.99e-12 | 1.05e+00 | 0.528 |
56977 | STOX2 | CCI_3 | Human | Cervix | CC | 6.58e-16 | 1.05e+00 | 0.516 |
56977 | STOX2 | CCII_1 | Human | Cervix | CC | 7.34e-11 | 5.60e-01 | 0.3249 |
56977 | STOX2 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.60e-04 | 4.17e-01 | 0.0338 |
56977 | STOX2 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 2.69e-02 | -1.29e-01 | 0.294 |
56977 | STOX2 | A014-C-108 | Human | Colorectum | FAP | 2.77e-14 | 8.54e-01 | -0.124 |
56977 | STOX2 | A002-C-114 | Human | Colorectum | FAP | 4.41e-03 | 5.04e-01 | -0.1561 |
56977 | STOX2 | A015-C-202 | Human | Colorectum | FAP | 1.01e-27 | 8.51e-01 | -0.0849 |
56977 | STOX2 | A018-E-020 | Human | Colorectum | FAP | 5.39e-10 | 7.48e-01 | -0.2034 |
56977 | STOX2 | AEH-subject1 | Human | Endometrium | AEH | 1.12e-18 | 4.41e-01 | -0.3059 |
56977 | STOX2 | AEH-subject2 | Human | Endometrium | AEH | 1.29e-05 | 2.97e-01 | -0.2525 |
56977 | STOX2 | AEH-subject3 | Human | Endometrium | AEH | 6.60e-12 | 3.52e-01 | -0.2576 |
56977 | STOX2 | AEH-subject5 | Human | Endometrium | AEH | 1.16e-03 | 2.18e-01 | -0.2953 |
56977 | STOX2 | EEC-subject1 | Human | Endometrium | EEC | 1.80e-13 | 4.54e-01 | -0.2682 |
56977 | STOX2 | EEC-subject2 | Human | Endometrium | EEC | 1.42e-04 | 2.81e-01 | -0.2607 |
56977 | STOX2 | EEC-subject3 | Human | Endometrium | EEC | 2.24e-03 | 2.66e-01 | -0.2525 |
56977 | STOX2 | TD9 | Human | Lung | IAC | 8.97e-03 | 6.13e-01 | 0.088 |
56977 | STOX2 | RNA-P10T2-P10T2-2 | Human | Lung | AAH | 2.70e-05 | 8.95e-01 | -0.1406 |
56977 | STOX2 | RNA-P10T2-P10T2-3 | Human | Lung | AAH | 1.23e-04 | 8.60e-01 | -0.1408 |
56977 | STOX2 | RNA-P10T2-P10T2-4 | Human | Lung | AAH | 4.35e-03 | 7.17e-01 | -0.138 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00018908 | Cervix | CC | placenta development | 40/2311 | 144/18723 | 4.59e-07 | 1.77e-05 | 40 |
GO:00614588 | Cervix | CC | reproductive system development | 87/2311 | 427/18723 | 1.37e-06 | 4.55e-05 | 87 |
GO:00486088 | Cervix | CC | reproductive structure development | 86/2311 | 424/18723 | 1.90e-06 | 5.97e-05 | 86 |
GO:00075654 | Cervix | CC | female pregnancy | 43/2311 | 193/18723 | 7.62e-05 | 1.04e-03 | 43 |
GO:00447064 | Cervix | CC | multi-multicellular organism process | 45/2311 | 220/18723 | 4.14e-04 | 4.21e-03 | 45 |
GO:00601353 | Cervix | CC | maternal process involved in female pregnancy | 15/2311 | 62/18723 | 7.30e-03 | 3.92e-02 | 15 |
GO:0001890 | Colorectum | AD | placenta development | 51/3918 | 144/18723 | 3.99e-05 | 7.16e-04 | 51 |
GO:0061458 | Colorectum | AD | reproductive system development | 116/3918 | 427/18723 | 1.11e-03 | 1.01e-02 | 116 |
GO:0048608 | Colorectum | AD | reproductive structure development | 114/3918 | 424/18723 | 1.78e-03 | 1.47e-02 | 114 |
GO:00018902 | Colorectum | MSS | placenta development | 51/3467 | 144/18723 | 1.10e-06 | 3.77e-05 | 51 |
GO:00614582 | Colorectum | MSS | reproductive system development | 115/3467 | 427/18723 | 9.86e-06 | 2.39e-04 | 115 |
GO:00486082 | Colorectum | MSS | reproductive structure development | 113/3467 | 424/18723 | 1.94e-05 | 4.18e-04 | 113 |
GO:0001893 | Colorectum | MSS | maternal placenta development | 13/3467 | 35/18723 | 7.38e-03 | 4.68e-02 | 13 |
GO:00018903 | Colorectum | FAP | placenta development | 38/2622 | 144/18723 | 6.22e-05 | 1.21e-03 | 38 |
GO:00614583 | Colorectum | FAP | reproductive system development | 85/2622 | 427/18723 | 4.30e-04 | 5.13e-03 | 85 |
GO:00486083 | Colorectum | FAP | reproductive structure development | 84/2622 | 424/18723 | 5.40e-04 | 6.10e-03 | 84 |
GO:00614589 | Endometrium | AEH | reproductive system development | 88/2100 | 427/18723 | 9.50e-09 | 6.41e-07 | 88 |
GO:00486089 | Endometrium | AEH | reproductive structure development | 87/2100 | 424/18723 | 1.43e-08 | 9.12e-07 | 87 |
GO:00018909 | Endometrium | AEH | placenta development | 39/2100 | 144/18723 | 1.07e-07 | 5.20e-06 | 39 |
GO:00075655 | Endometrium | AEH | female pregnancy | 43/2100 | 193/18723 | 7.52e-06 | 1.80e-04 | 43 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
STOX2 | SNV | Missense_Mutation | novel | c.1979G>A | p.Gly660Glu | p.G660E | Q9P2F5 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.998) | TCGA-CV-6941-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
STOX2 | SNV | Missense_Mutation | rs767593643 | c.616N>A | p.Val206Met | p.V206M | Q9P2F5 | protein_coding | tolerated(0.48) | benign(0) | TCGA-F7-A624-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
STOX2 | SNV | Missense_Mutation | c.524C>A | p.Pro175His | p.P175H | Q9P2F5 | protein_coding | tolerated(0.28) | benign(0.12) | TCGA-HC-A4ZV-01 | Prostate | prostate adenocarcinoma | Male | <65 | 9 | Unknown | Unknown | SD | |
STOX2 | SNV | Missense_Mutation | novel | c.365N>T | p.Thr122Met | p.T122M | Q9P2F5 | protein_coding | tolerated(1) | benign(0.003) | TCGA-XJ-A83F-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 7 | Unknown | Unknown | SD |
STOX2 | SNV | Missense_Mutation | c.491N>A | p.Ile164Lys | p.I164K | Q9P2F5 | protein_coding | tolerated(0.12) | benign(0.047) | TCGA-BR-4257-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
STOX2 | SNV | Missense_Mutation | rs776429999 | c.589N>A | p.Asp197Asn | p.D197N | Q9P2F5 | protein_coding | tolerated(0.22) | probably_damaging(0.981) | TCGA-BR-8382-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
STOX2 | SNV | Missense_Mutation | novel | c.2633N>C | p.Asn878Thr | p.N878T | Q9P2F5 | protein_coding | deleterious_low_confidence(0.01) | benign(0.351) | TCGA-BR-8589-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
STOX2 | SNV | Missense_Mutation | c.1781N>G | p.Lys594Arg | p.K594R | Q9P2F5 | protein_coding | deleterious_low_confidence(0.01) | benign(0.321) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
STOX2 | SNV | Missense_Mutation | novel | c.1573N>A | p.Gln525Lys | p.Q525K | Q9P2F5 | protein_coding | tolerated(0.09) | benign(0.024) | TCGA-CG-4305-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | CR |
STOX2 | SNV | Missense_Mutation | novel | c.656N>T | p.Ala219Val | p.A219V | Q9P2F5 | protein_coding | tolerated(0.12) | benign(0.24) | TCGA-HF-A5NB-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | fluorouracil | SD |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |